Spine BioPharma, Inc. — Form D
Spine BioPharma, Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2022-03-24. The offering totals $30.4M, of which $13.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2022-03-24
- Form: D
- Accession: 0001852647-22-000003
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $30.4M
- Amount sold: $13.0M
- Remaining: $17.4M
- Investors: 6
- Date of first sale: 2022-03-17
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-438672
Issuer
- Name: Spine BioPharma, Inc.
- CIK: 0001852647
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 505 PARK AVENUE, 14TH FLOOR, NEW YORK, NY, 10022
- Phone: 212-583-9700
Officers, directors & promoters (14)
| Name | Role | Location |
|---|
| Thomas R Bumol, PhD | Director | New York, NY |
| Fran R Magee | Executive Officer | New York, NY |
| Jason J Gallagher | Executive Officer | New York, NY |
| Frank R Cammisa, MD | Director | New York, NY |
| Marc R Viscogliosi | Director | New York, NY |
| Marc R Viscogliosi | Executive Officer | New York, NY |
| LLC J Viscogliosi Brothers, | Executive Officer | New York, NY |
| John J Viscogliosi | Director | New York, NY |
| John J Viscogliosi | Executive Officer | New York, NY |
| Marc R. Viscogliosi | Related Person | New York, NY |
| Fran Magee | Related Person | New York, NY |
| Thomas Bumol, PhD | Related Person | New York, NY |
| Frank Cammisa, MD | Related Person | New York, NY |
| John J. Viscogliosi | Related Person | New York, NY |
Other filings by this issuer (7)
More